Notices
Notice No20200214-42Notice Date14 Feb 2020
CategoryTradingSegmentEquity
SubjectOpening of Offer to Buy – Acquisition Window (Buyback) for Aster DM Healthcare Limited
Content

Trading Members and Custodians are requested to note that Securities Exchange Board of India (SEBI) has issued Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and De-listing, vide its circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015 and no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016. The Exchange vide its notice no. 20170210-16 dated Feb 10, 2017, and 20190207-23 dated 07 Feb 2019 has issued Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and Delisting.

 

All market participants are hereby informed that Aster DM Healthcare Limited (the “Company”), has announced an offer for buyback of up to 57,14,285 (Fifty-Seven Lakhs Fourteen Thousand Two Hundred And Eighty Five) fully paid-up equity shares of face value of Rs. 10/- (Rupees Ten Only) each of the Company representing approximately 1.13% of the total paid-up equity share Capital of the company at a price of Rs. 210/- (Rupees Two Hundred And Ten Only) per equity share (“Buyback Price”) payable in cash for an aggregate amount of up to Rs. 120 Crores/- (Rupees One Hundred And Twenty Crores Only) (“Buyback Size”), which is 4.69% of the fully paid-up equity share capital and free reserves as per the latest audited standalone financial statements of the Company as at March 31, 2019 and 5.42% of the fully paid-up equity share capital and free reserves as per the latest audited consolidated financial statements of the Company as at March 31, 2019, on a proportionate basis through the “Tender Offer” route as prescribed under the Buyback Regulations from all of the Shareholders of the Company who hold equity shares as on the Record Date i.e  January 24, 2020, from Thursday, February 20, 2020  to Thursday, March 5, 2020.

 

Market participants are further requested to note that this offer will be as per the Revised Guidelines of SEBI circular no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016 and Exchange notice no. 20170210-16 dated Feb 10, 2017 and the details of this Offer to Buy would be available on BSE Website – www.bseindia.com.

 

 

Bhushan Mokashi

Additional General Manager

Listing Sales & Ops

February 14,2020

 

Attachments
Letter of Offer.pdf